pregnancy. Other specified complications of labour and delivery
Conditions
Interventions
Intervention 1: .patients in control group only received equal amount of normal saline as placebo. Intervention 2: patients in intervention group were received 50 mg/kg intravenous Mg sulphate in 100
Placebo
Treatment - Drugs
.patients in control group only received equal amount of normal saline as placebo.
patients in intervention group were received 50 mg/kg intravenous Mg sulphate in 100 ml normal saline in 15 minutes just before surgical incision and 15 mg/kg/hr IV infusion of Mg sulphate thereafter
Sponsors
Tehran university of medical sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: inclusion criteria: pregnant women with ASA I,II (American Society of Anesthesiologists) scheduled for elective Cesarian section under general anesthesia exclusion criteria: hypermagnesemia, insufficient time for giving study drugs,sensitivity to magnesium sulphate, heart blocks,hypertension,diabetes,renal disease, cardiovascular disease,history of analgesic intake during the past 24 hours,fetal distress, multiparity
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of postoperative pain. Timepoint: 1st, 6th,12th,24th hours after cesarian section. Method of measurement: short MCGillL pain questionaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemodynamic changes( blood pressure and heart rate). Timepoint: at induction and tracheal intubation and during surgical procedure and in recovery period. Method of measurement: by means of a mercury manometre and a cardiac monitor.;Analgesic requirements. Timepoint: during 24 hours after completion of cesarian section. Method of measurement: by means of recorded amounts of infused analgesic which displayed on a PCA pomp. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactseyed mohammad mireskandari
tehran university of medical sciences
Outcome results
None listed